Possible Prolongation of Remission in Acute Myeloid Leukemia by Granulocyte Transfusions
- 6 March 1980
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 302 (10) , 583-584
- https://doi.org/10.1056/nejm198003063021016
Abstract
To the Editor: Adoptive immunotherapy — the transfer of immunologically competent allogenic cells — can destroy residual cancer cells and result in long-term "cures" in tumor-bearing animals given sublethal chemotherapy or radiotherapy.1 2 3 4 In human beings a similar antitumor effect has been demonstrated in patients with leukemia treated with marrow transplantation; decrease in leukemic relapse has been observed in patients with graft-versus-host disease (GVHD).5 Although a number of cases of GVHD have followed granulocytc transfusions,6 7 8 demonstrating that these collections contain biologically important numbers of lymphocytes, no report of an antitumor effect in recipients has been published. We performed a prospectively randomized . . .Keywords
This publication has 6 references indexed in Scilit:
- Nonfatal graft-versus-host disease occurring after transfusion with leukocytes and platelets obtained from normal donorsBlood, 1979
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- Acute leukemia and granulocyte transfusion: Fatal graft-versus-host reaction following transfusion of cells obtained from normal donorsThe Journal of Pediatrics, 1978
- FATAL GRAFT-VERSUS-HOST DISEASE FOLLOWING TRANSFUSION OF GRANULOCYTES FROM NORMAL DONORSThe Lancet, 1976
- ALLOGENEIC BONE MARROW CHIMERISM IN GERM-FREE MICETransplantation, 1976
- Allogeneic Bone Marrow Chimerism in Germfree Mice III. Therapy of Leukemic AKR MiceExperimental Biology and Medicine, 1974